Adrià Rofes1,2, Emmanuel Mandonnet3,4,5, John Godden6, Marie Hélène Baron7, Henry Colle8, Amelie Darlix9, Vânia de Aguiar10,11, Hugues Duffau12,13, Guillaume Herbet12,13, Martin Klein14, Vincent Lubrano15, Juan Martino16, Ryan Mathew6, Gabriele Miceli17, Sylvie Moritz-Gasser12,13,18, Johan Pallud19,20,21, Costanza Papagno17,22, Fabien Rech23, Erik Robert8, Geert-Jan Rutten24, Thomas Santarius25, Djaina Satoer26, Joanna Sierpowska27, Anja Smits28,29, Miran Skrap30, Giannantonio Spena31, Evy Visch26, Elke De Witte32, Maria Zetterling28, Michel Wager33. 1. Global Brain Health Institute, Trinity College, Dublin, Ireland. rofesa@tcd.ie. 2. Trinity College Institute of Neuroscience, Trinity College, Dublin, Ireland. rofesa@tcd.ie. 3. Department of Neurosurgery, Lariboisière Hospital APHP, Paris, France. 4. University Paris 7, Paris, France. 5. IMNC UMR8165, Orsay, France. 6. Department of Neurosurgery, Leeds General Infirmary, Leeds, UK. 7. Department of Radiotherapy, University Hospital of Besançon, Besançon, France. 8. AZ Sint-Lucas and AZ Maria Middelares, Ghent, Netherlands. 9. Department of Medical Oncology, Institut Régional du Cancer de Montpellier (ICM), Montpellier, France. 10. Global Brain Health Institute, Trinity College, Dublin, Ireland. 11. School of Linguistic, Speech and Communication Sciences, Trinity College, Dublin, Ireland. 12. Department of Neurosurgery, Gui de Chauliac Hospital, Institute for Neurosciences of Montpellier, University of Montpellier, Montpellier, France. 13. Institute for Neuroscience of Montpellier, Saint Eloi Hospital, Montpellier University Medical Centre, Montpellier, France. 14. Department of Medical Psychology, VU University Medical Centre, Amsterdam, The Netherlands. 15. Department of Neurosurgery, Centre Hospitalier Universitaire, Toulouse, France. 16. Department of Neurological Surgery, Hospital Universitario Marqués de Valdecilla and Fundación Instituto de Investigación Marqués de Valdecilla, Santander, Spain. 17. Centre for Mind/Brain Sciences and Centre for Neurocognitive Rehabilitation, University of Trento, Rovereto, Italy. 18. Department of Neurology, Gui de Chauliac Hospital, Montpellier University Medical Centre, Montpellier, France. 19. Department of Neurosurgery, Sainte-Anne Hospital, Paris, France. 20. Paris Descartes University, Sorbonne Paris Cité, Paris, France. 21. Inserm, U894, Centre Psychiatrie et Neurosciences, Paris, France. 22. Dipartimento di Psicologia, Università di Milano-Bicocca, Milan, Italy. 23. Department of Neurosurgery CHU Nancy, Nancy, France. 24. Department of Neurosurgery, St Elisabeth-Tweesteden Hospital, Tilburg, The Netherlands. 25. Department of Clinical Neurosciences, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK. 26. Department of Neurosurgery Erasmus MC, University Medical Centre, Rotterdam, The Netherlands. 27. Department of Cognition, Development and Education Psychology, University of Barcelona, Barcelona, Spain. 28. Department of Neuroscience, Neurology, Uppsala University, Uppsala, Sweden. 29. Department of Clinical Neurosciences and Rehabilitation, Sahlgrenska Academy, Institute of Neurosciences and Physiology, University of Gothenburg, Gothenburg, Sweden. 30. Department of Neurosurgery, University Hospital of Udine, Udine, Italy. 31. Department of Neurosurgery, University of Brescia, Brescia, Italy. 32. Department of Linguistics and Literary Studies, Clinical and Experimental Neurolinguistics, Free University of Brussels, Brussels, Belgium. 33. Department of Neurosurgery, Poitiers University Hospital, INSERM U1084, Poitiers, France.
Abstract
BACKGROUND: The European Low-Grade Glioma network indicated a need to better understand common practices regarding the managing of diffuse low-grade gliomas. This area has experienced great advances in recent years. METHOD: A general survey on the managing of diffuse low-grade gliomas was answered by 21 centres in 11 European countries. Here we focused on specific questions regarding perioperative and intraoperative cognitive assessments. RESULTS: More centres referred to the same speech and language therapist and/or neuropsychologist across all assessments; a core of assessment tools was routinely used across centres; fluency tasks were commonly used in the perioperative stages, and object naming during surgery; tasks that tapped on attention, executive functions, visuospatial awareness, calculation and emotions were sparsely administered; preoperative assessments were performed 1 month or 1 week before surgery; timing for postoperative assessments varied; finally, more centres recommended early rehabilitation, whenever needed. CONCLUSIONS: There is an emerging trend towards following similar practices for the management of low-grade gliomas in Europe. Our results are descriptive and formalise current discussions in our group. Also, they contribute towards the development of a European assessment protocol.
BACKGROUND: The European Low-Grade Glioma network indicated a need to better understand common practices regarding the managing of diffuse low-grade gliomas. This area has experienced great advances in recent years. METHOD: A general survey on the managing of diffuse low-grade gliomas was answered by 21 centres in 11 European countries. Here we focused on specific questions regarding perioperative and intraoperative cognitive assessments. RESULTS: More centres referred to the same speech and language therapist and/or neuropsychologist across all assessments; a core of assessment tools was routinely used across centres; fluency tasks were commonly used in the perioperative stages, and object naming during surgery; tasks that tapped on attention, executive functions, visuospatial awareness, calculation and emotions were sparsely administered; preoperative assessments were performed 1 month or 1 week before surgery; timing for postoperative assessments varied; finally, more centres recommended early rehabilitation, whenever needed. CONCLUSIONS: There is an emerging trend towards following similar practices for the management of low-grade gliomas in Europe. Our results are descriptive and formalise current discussions in our group. Also, they contribute towards the development of a European assessment protocol.
Authors: Joanna Sierpowska; Adrià Rofes; Kristoffer Dahlslätt; Emmanuel Mandonnet; Mark Ter Laan; Monika Połczyńska; Philip De Witt Hamer; Matej Halaj; Giannantonio Spena; Torstein R Meling; Kazuya Motomura; Andrés Felipe Reyes; Alexandre Rainha Campos; Pierre A Robe; Luca Zigiotto; Silvio Sarubbo; Christian F Freyschlag; Martijn P G Broen; George Stranjalis; Konstantinos Papadopoulos; Evangelia Liouta; Geert-Jan Rutten; Catarina Pessanha Viegas; Ana Silvestre; Federico Perrote; Natacha Brochero; Cynthia Cáceres; Agata Zdun-Ryżewska; Wojciech Kloc; Djaina Satoer; Olga Dragoy; Marc P H Hendriks; Juan C Alvarez-Carriles; Vitória Piai Journal: Neurooncol Pract Date: 2022-04-04
Authors: William Jarrold; Adria Rofes; Stephen Wilson; Peter Pressman; Edward Stabler; Marilu Gorno-Tempini Journal: Annu Int Conf IEEE Eng Med Biol Soc Date: 2020-07